Revenues in USD of Niagen Bioscience, Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Niagen Bioscience, Inc. quarterly/annual Revenues history and change rate from Q2 2010 to Q3 2025.
  • Niagen Bioscience, Inc. Revenues for the quarter ending 30 Sep 2025 was $34M, a 32.9% increase year-over-year.
  • Niagen Bioscience, Inc. Revenues for the twelve months ending 30 Sep 2025 was $125M, a 36% increase year-over-year.
  • Niagen Bioscience, Inc. annual Revenues for 2024 was $99.6M, a 19.2% increase from 2023.
  • Niagen Bioscience, Inc. annual Revenues for 2023 was $83.6M, a 16% increase from 2022.
  • Niagen Bioscience, Inc. annual Revenues for 2022 was $72.1M, a 6.82% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Niagen Bioscience, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $125M $34M +$8.41M +32.9% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $116M $31.1M +$8.38M +36.8% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $108M $30.5M +$8.33M +37.6% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $99.6M $29.1M +$7.93M +37.4% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025
Q3 2024 $91.7M $25.6M +$6.09M +31.2% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 $85.6M $22.7M +$2.42M +11.9% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $83.2M $22.2M -$403K -1.79% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $83.6M $21.2M +$200K +0.95% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 $83.4M $19.5M +$2.43M +14.3% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $80.9M $20.3M +$3.59M +21.5% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $77.3M $22.6M +$5.3M +30.7% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $72.1M $21M +$3.24M +18.2% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $68.8M $17.1M -$245K -1.42% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $69.1M $16.7M -$967K -5.46% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $70M $17.3M +$2.58M +17.5% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $67.4M $17.8M +$2.31M +15% 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2023
Q3 2021 $65.1M $17.3M +$3.13M +22.1% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $62M $17.7M +$2.41M +15.8% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $59.6M $14.7M +$338K +2.36% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $59.3M $15.4M +$2.36M +18% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 $56.9M $14.2M +$2.13M +17.6% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $54.8M $15.3M +$4.19M +37.7% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $50.6M $14.3M +$4.3M +42.8% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $46.3M $13.1M +$4.02M +44.4% 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 $42.3M $12.1M +$3.93M +48.4% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $38.3M $11.1M +$3.3M +42.3% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $35M $10M +$3.48M +53% 01 Jan 2019 31 Mar 2019 10-Q 18 May 2020
Q4 2018 $31.6M $9.07M -$1.83M -16.8% 01 Oct 2018 31 Dec 2018 10-K 10 Mar 2020
Q3 2018 $33.4M $8.12M +$2.04M +33.5% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $31.4M $7.8M +$3.59M +85% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $27.8M $6.57M +$6.57M 31 Dec 2017 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $21.2M $10.9M 01 Oct 2017 30 Dec 2017 10-K 07 Mar 2019
Q3 2017 $6.08M 02 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 $4.22M 02 Apr 2017 01 Jul 2017 10-Q 09 Aug 2018
Q1 2017 $0 01 Jan 2017 01 Apr 2017 10-Q 10 May 2018
Q2 2011 $1.94M -$95.9K -4.71% 03 Apr 2011 02 Jul 2011 10-Q 11 Aug 2011
Q2 2010 $2.03M 04 Apr 2010 03 Jul 2010 10-Q 11 Aug 2011

Niagen Bioscience, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $99.6M +$16M +19.2% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025
2023 $83.6M +$11.5M +16% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025
2022 $72.1M +$4.6M +6.82% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 $67.4M +$8.19M +13.8% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023
2020 $59.3M +$13M +28% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022
2019 $46.3M +$14.7M +46.7% 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021
2018 $31.6M +$10.4M +48.8% 31 Dec 2017 31 Dec 2018 10-K 10 Mar 2020
2017 $21.2M 01 Jan 2017 30 Dec 2017 10-K 07 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.